腸外營養市場規模、佔有率、趨勢分析報告:依階段類型、營養類型、適應症、銷售管道、地區、細分市場趨勢,2023-2030
市場調查報告書
商品編碼
1321393

腸外營養市場規模、佔有率、趨勢分析報告:依階段類型、營養類型、適應症、銷售管道、地區、細分市場趨勢,2023-2030

Parenteral Nutrition Market Size, Share & Trends Analysis Report By Stage Type (Adults, Pediatrics), By Nutrient Type, By Indication, By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

腸外營養市場成長與趨勢

Grand View Research, Inc.最新報告顯示,到2030年,全球腸外營養市場規模預計將達到107億美元,預測期內年複合成長率為6.0%。

癌症、糖尿病和其他神經系統疾病等慢性疾病的增加,重症患者基本營養缺乏的急劇增加,以及對醫院相關營養不良的認知不斷提高,是推動腸外營養採用增加的關鍵要素 。腸外給藥具有起效快、劑量低的優點,並且可以防止飲食不均衡引起的各種副作用,推動市場成長。

然而,給藥過程中感染的高風險以及患者對經腸營養的偏好是限制市場成長的主要要素。隨著人口的增加,家庭和國家的醫療保健和食品成本不斷增加。因此,出生率上升預計將影響營養水準,成為市場促進因素。實現的出生率比絕對出生率(粗出生率)更重要,因為出生率包括環境以及資源壓力,例如每次出生所需的水、食物和藥物的數量發揮作用。過去十年來,實際出生率有所上升,預計在預測期內將保持成長。

國家衛生統計中心 (NCHS) 報告2020年出生率為每 1000 人 11.99 人。此外,低出生體重嬰兒的比例8.0%,推動了全球對 PN 產品的需求。此外,60歲以上老年人口眾多,免疫力低下,神經系統疾病、心臟病、癌症、脊柱損傷等的高發生率也是預測期內非口服脂質乳劑市場的促進因素。 這些人群預計將能夠獲得現代外科治療,這有望延長壽命並增加對加護治療和術後治療的需求,包括脂質乳劑等 PN 產品。

腸外營養市場報告亮點

  • 市場上營運的主要企業主要致力於提高病患安全。各企業也致力於透過結合條碼輔助給藥等技術來開發 PN 產品,以補充腸外營養配方。
  • 為患者提供改進的脂質和蛋白質配方的能力是公司將其產品與競爭差別化的關鍵參數之一。
  • 此外,感染率高、水質和衛生條件差以及缺乏認知是新興國家營養不良發生率增加的常見要素,這對PN源產生了巨大的需求並增加了市場佔有率,促進了成長。
  • 2022年,由於副作用較少的新型氨基酸溶液的出現,單劑量氨基酸溶液營養劑類型主導了市場。
  • 到2022年,成人細分市場將佔據最大佔有率,因為該年齡層的阿茲海默症、肌少症、癌症和糖尿病等各種慢性疾病的盛行率不斷上升,因此擴大採用腸外營養產品。
  • 由於克隆氏症、囊性纖維化、胰臟炎、其他癌症相關治療和其他健康疾病的盛行率不斷增加,其他適應症細分市場將在2022年佔據主導地位。
  • 2022年,由於私人和公立醫療機構數量眾多,慢性疾病患者增加,銷售管道佔據市場主導地位。
  • 由於慢性病和營養不良的罹患率上升,以及美國FDA 批准的增加,北美將在2022年主導全球市場。

目錄

第1章 調查方法和範圍

  • 調查過程
  • 資訊採購
  • 調查方法
  • 調查範圍和先決條件
  • 調查方法
  • 資料列表

第2章 執行摘要

第3章 腸外營養市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 附隨市場預測
  • 從使用者觀點分析
    • 消費行為分析
    • 市場影響力分析
  • 法律規範
    • 償付框架
    • 標準和合規性
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
    • 產業挑戰
  • 腸外營養市場分析工具
    • 產業分析-波特
    • PESTEL分析
  • COVID-19 對腸外營養市場的影響

第4章 腸外營養市場:營養類型的估算與趨勢分析

  • 細分儀表板
  • 腸外營養市場:2022年和2030年營養類型變化分析
    • 碳水化合物
    • 腸外脂質乳劑
    • 單劑量氨基酸溶液
    • 微量元素
    • 維生素和礦物質

第5章 腸外營養市場:階段類型估計與趨勢分析

  • 細分儀表板
  • 腸外營養市場:2022年和2030年階段類型變化分析
    • 成人
    • 孩子

第6章 腸外營養市場:適應症估計與估計/趨勢分析

  • 細分儀表板
  • 腸外營養市場:2022年及2030年適應症變化分析
    • 阿茲海默氏症
    • 營養缺乏
    • 癌症治療
    • 糖尿病
    • 慢性腎臟病
    • 罕見疾病
    • 吞嚥困難
    • 疼痛管理
    • 吸收不良/胃腸道疾病/腹瀉
    • 其他

第7章 腸外營養市場:銷售管道估算及趨勢分析

  • 細分儀表板
  • 腸外營養市場:2022年及2030年銷售管道變化分析
    • 網路銷售
    • 零售銷售
    • 機構銷售

第8章 腸外營養市場:區域估計與趨勢分析

  • 定義和範圍
  • 2022年及2030年區域市佔率分析
  • 區域市場儀表板
  • 區域市場簡介
  • 2022年至2030年市場規模、預測、收入及趨勢分析
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東、非洲

第9章 競爭形勢

  • 公司分類
  • 主要企業市場分析
  • 主要企業市佔率分析
  • 主要市場參與企業的最新發展和影響分析
  • 公司簡介
    • Braun Melsungen AG
    • Fresenius kabi AG
    • Allergan
    • Grifols SA
    • Pfizer Inc.
    • Otsuka Pharmaceutical Factory, Inc
    • Baxter
    • Aculife
    • Sichuan Kelun Pharmaceutical Co., Ltd
    • Vifor Pharma
Product Code: 978-1-68038-867-1

Parenteral Nutrition Market Growth & Trends

The global parenteral nutrition market size is expected to reach USD 10.7 billion by 2030, registering a CAGR of 6.0% over the forecast period, according to a new report by Grand View Research, Inc. Growing incidences of chronic diseases, such as cancer, diabetes, and other neurological conditions; surge in essential nutrition deficiency among critically ill patients; and growing awareness pertaining to hospital-related malnutrition are few key factors increasing the adoption of parenteral nutrition. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth.

However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. With the increasing population, healthcare costs and food expenditures for a household and the nation are growing. Hence, a higher birth rate is expected to impact nutrition levels, thereby acting as a driver for the market. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and is anticipated to maintain growth over the forecast period.

In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) is 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide. Furthermore, the presence of a large population base, aged above 60 years, suffering from low immunity levels, and prone to incidence of neurological diseases, cardiac problems, cancers, and spinal injuries, is a high-impact rendering driver for the parenteral lipid emulsions market over the forecast period. This population is expected to avail the latest surgical treatments, which is expected to increase their life span, thereby driving the need for intensive care & postoperative treatment, inclusive of PN products, such as lipid emulsions.

Parenteral Nutrition Market Report Highlights

  • Key players operating in the market are mainly focused on enhancing patient safety. Companies are also focusing on advancing their PN products to complement the parenteral nutrition compounding by incorporating technologies, such as barcode-assisted medication.
  • The ability to provide improved lipid and protein formulations to patients is one of the key parameters that companies leverage to differentiate their products from competitors
  • Also, high infection rates, poor water quality & sanitation facilities, and lack of awareness are prevalent factors increasing the incidence of malnourishment in developing nations, which creates a significant demand for PN sources, thereby aiding market growth
  • The single-dose amino acid solution nutrient type segment dominated the market in 2022 due to the introduction of newly available amino acid solutions with minimal side effects
  • In 2022, the adult segment held the largest share due to increased adoption of parenteral nutrition products owing to the rising prevalence of various chronic diseases, such as Alzheimer's disease, sarcopenia, cancer, and diabetes among this age group
  • The others indication segment dominated the market in 2022 due to the increased prevalence of Crohn's disease, cystic fibrosis, pancreatitis, other cancer-related treatment, and other health ailments
  • In 2022, institutional sales channels dominated the market owing to the high number of private & public healthcare institutions and the increased patient population with chronic disease
  • North America dominated the global market in 2022 owing to the rising incidence of chronic conditions & malnutrition, coupled with increasing U.S. FDA approvals in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Research Process
  • 1.2. Information Procurement
    • 1.2.1. Purchased database
      • 1.2.1.1. GVR's internal database
    • 1.2.2. Market Formulation & Validation
  • 1.3. Research Methodology
  • 1.4. Research Scope and Assumptions
  • 1.5. Research Methodology
    • 1.5.1. Region Market: CAGR Calculation
    • 1.5.2. Region Based Segment Share Calculation
  • 1.6. List To Data Nutrient Type

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights
  • 2.4. Parenteral Nutrition Market Snapshot

Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Ancillary Market Outlook
  • 3.2. User Perspective Analysis
    • 3.2.1. Consumer Behavior Analysis
    • 3.2.2. Market Influencer Analysis
  • 3.3. Regulatory Framework
    • 3.3.1. Reimbursement Framework
    • 3.3.2. Standard & Compliance
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
    • 3.4.3. Industry Challenge
  • 3.5. Parenteral Nutrition Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Bargaining power of the suppliers
      • 3.5.1.2. Bargaining power of the buyers
      • 3.5.1.3. Threats of substitution
      • 3.5.1.4. Threats from new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Economic and Social landscape
      • 3.5.2.3. Technological landscape
  • 3.6. Impact of COVID 19 on Parenteral Nutrition Market

Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Parenteral Nutrition Market: Nutrient Type Movement Analysis, 2022 & 2030 (USD Million)
    • 4.2.1. Carbohydrates
      • 4.2.1.1. Carbohydrates Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.2. Parenteral Lipid Emulsion
      • 4.2.2.1. Parenteral Lipid Emulsion Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.3. Single Dose Amino Acid Solution
      • 4.2.3.1. Single Dose Amino Acid Solution Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.4. Trace Elements
      • 4.2.4.1. Trace Elements Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 4.2.5. Vitamins & Minerals
      • 4.2.5.1. Vitamins & Minerals Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Parenteral Nutrition Market: Stage Type Movement Analysis, 2022 & 2030 (USD Million)
    • 5.2.1. Adult
      • 5.2.1.1. Adult Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.2.2. Pediatrics
      • 5.2.2.1. Pediatrics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Parenteral Nutrition Market: Indication Movement Analysis, 2022 & 2030 (USD Million)
    • 6.2.1. Alzheimer's
      • 6.2.1.1. Alzheimer's Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. Nutrition Deficiency
      • 6.2.2.1. Nutrition Deficiency Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Cancer Care
      • 6.2.3.1. Cancer Care Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Diabetes
      • 6.2.4.1. Diabetes Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.5. Chronic Kidney Disease
      • 6.2.5.1. Chronic Kidney Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.6. Orphan Disease
      • 6.2.6.1. Orphan Disease Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.7. Dysphagia
      • 6.2.7.1. Dysphagia Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.8. Pain Management
      • 6.2.8.1. Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.9. Malabsorption/GI Disorder/Diarrhea
      • 6.2.9.1. Malabsorption/GI Disorder/Diarrhea Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.2.10. Others
      • 6.2.10.1. Others Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Parenteral Nutrition Market: Sales Channel Movement Analysis, 2022 & 2030 (USD Million)
    • 7.2.1. Online Sales
      • 7.2.1.1. Online Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. Retail Sales
      • 7.2.2.1. Retail Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Institutional Sales
      • 7.2.3.1. Institutional Sales Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis

  • 8.1. Definition & Scope
  • 8.2. Regional Market Share Analysis, 2022 & 2030
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
    • 8.5.1. North America
      • 8.5.1.1. North America Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.1.2. U.S.
      • 8.5.1.2.1. Key Country Dynamics
      • 8.5.1.2.2. Competitive Scenario
      • 8.5.1.2.3. Regulatory Framework
      • 8.5.1.2.4. Reimbursement Scenario
      • 8.5.1.2.5. U.S. Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.1.3. Canada
      • 8.5.1.3.1. Key Country Dynamics
      • 8.5.1.3.2. Competitive Scenario
      • 8.5.1.3.3. Regulatory Framework
      • 8.5.1.3.4. Reimbursement Scenario
      • 8.5.1.3.5. Canada Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.2. Europe
      • 8.5.2.1. Europe Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.2. UK
      • 8.5.2.2.1. Key Country Dynamics
      • 8.5.2.2.2. Competitive Scenario
      • 8.5.2.2.3. Regulatory Framework
      • 8.5.2.2.4. Reimbursement Scenario
      • 8.5.2.2.5. UK Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.3. Germany
      • 8.5.2.3.1. Key Country Dynamics
      • 8.5.2.3.2. Competitive Scenario
      • 8.5.2.3.3. Regulatory Framework
      • 8.5.2.3.4. Reimbursement Scenario
      • 8.5.2.3.5. Germany Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.4. France
      • 8.5.2.4.1. Key Country Dynamics
      • 8.5.2.4.2. Competitive Scenario
      • 8.5.2.4.3. Regulatory Framework
      • 8.5.2.4.4. Reimbursement Scenario
      • 8.5.2.4.5. France Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.5. Italy
      • 8.5.2.5.1. Key Country Dynamics
      • 8.5.2.5.2. Competitive Scenario
      • 8.5.2.5.3. Regulatory Framework
      • 8.5.2.5.4. Reimbursement Scenario
      • 8.5.2.5.5. Italy Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.6. Spain
      • 8.5.2.6.1. Key Country Dynamics
      • 8.5.2.6.2. Competitive Scenario
      • 8.5.2.6.3. Regulatory Framework
      • 8.5.2.6.4. Reimbursement Scenario
      • 8.5.2.6.5. Spain Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.7. Denmark
      • 8.5.2.7.1. Key Country Dynamics
      • 8.5.2.7.2. Competitive Scenario
      • 8.5.2.7.3. Regulatory Framework
      • 8.5.2.7.4. Reimbursement Scenario
      • 8.5.2.7.5. Denmark Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.8. Sweden
      • 8.5.2.8.1. Key Country Dynamics
      • 8.5.2.8.2. Competitive Scenario
      • 8.5.2.8.3. Regulatory Framework
      • 8.5.2.8.4. Reimbursement Scenario
      • 8.5.2.8.5. Sweden Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.2.9. Norway
      • 8.5.2.9.1. Key Country Dynamics
      • 8.5.2.9.2. Competitive Scenario
      • 8.5.2.9.3. Regulatory Framework
      • 8.5.2.9.4. Reimbursement Scenario
      • 8.5.2.9.5. Norway Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.3. Asia Pacific
      • 8.5.3.1. Asia Pacific Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.2. Japan
      • 8.5.3.2.1. Key Country Dynamics
      • 8.5.3.2.2. Competitive Scenario
      • 8.5.3.2.3. Regulatory Framework
      • 8.5.3.2.4. Reimbursement Scenario
      • 8.5.3.2.5. Japan Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.3. India
      • 8.5.3.3.1. Key Country Dynamics
      • 8.5.3.3.2. Competitive Scenario
      • 8.5.3.3.3. Regulatory Framework
      • 8.5.3.3.4. Reimbursement Scenario
      • 8.5.3.3.5. India Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.4. China
      • 8.5.3.4.1. Key Country Dynamics
      • 8.5.3.4.2. Competitive Scenario
      • 8.5.3.4.3. Regulatory Framework
      • 8.5.3.4.4. Reimbursement Scenario
      • 8.5.3.4.5. China Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.5. Australia
      • 8.5.3.5.1. Key Country Dynamics
      • 8.5.3.5.2. 8. 6. 3.5Competitive Scenario
      • 8.5.3.5.3. Regulatory Framework
      • 8.5.3.5.4. Reimbursement Scenario
      • 8.5.3.5.5. Australia Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.6. Thailand
      • 8.5.3.6.1. Key Country Dynamics
      • 8.5.3.6.2. 8. Competitive Scenario
      • 8.5.3.6.3. Regulatory Framework
      • 8.5.3.6.4. Reimbursement Scenario
      • 8.5.3.6.5. Thailand Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.3.7. South Korea
      • 8.5.3.7.1. Key Country Dynamics
      • 8.5.3.7.2. 8. 6. 3.7Competitive Scenario
      • 8.5.3.7.3. Regulatory Framework
      • 8.5.3.7.4. Reimbursement Scenario
      • 8.5.3.7.5. South Korea Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.6 Latin America
      • 8.5.6.1. Latin America Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.6.2. Brazil
      • 8.5.6.2.1. Key Country Dynamics
      • 8.5.6.2.2. Competitive Scenario
      • 8.5.6.2.3. Regulatory Framework
      • 8.5.6.2.4. Reimbursement Scenario
      • 8.5.6.2.5. Brazil Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.6.3. Mexico
      • 8.5.6.3.1. Key Country Dynamics
      • 8.5.6.3.2. Competitive Scenario
      • 8.5.6.3.3. Regulatory Framework
      • 8.5.6.3.4. Reimbursement Scenario
      • 8.5.6.3.5. 6. 4.3.5 Mexico Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.6.4. Argentina
      • 8.5.6.4.1. Key Country Dynamics
      • 8.5.6.4.2. Competitive Scenario
      • 8.5.6.4.3. Regulatory Framework
      • 8.5.6.4.4. Reimbursement Scenario
      • 8.5.6.4.5. Argentina Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.5.7. MEA
      • 8.5.7.1. MEA Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.7.2. South Africa
      • 8.5.7.2.1. Key Country Dynamics
      • 8.5.7.2.2. Competitive Scenario
      • 8.5.7.2.3. Regulatory Framework
      • 8.5.7.2.4. Reimbursement Scenario
      • 8.5.7.2.5. South Africa Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.7.3. Saudi Arabia
      • 8.5.7.3.1. Key Country Dynamics
      • 8.5.7.3.2. Competitive Scenario
      • 8.5.7.3.3. Regulatory Framework
      • 8.5.7.3.4. Reimbursement Scenario
      • 8.5.7.3.5. Saudi Arabia Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.7.4. UAE
      • 8.5.7.4.1. Key Country Dynamics
      • 8.5.7.4.2. Competitive Scenario
      • 8.5.7.4.3. Regulatory Framework
      • 8.5.7.4.4. Reimbursement Scenario
      • 8.5.7.4.5. UAE Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)
      • 8.5.7.5. Kuwait
      • 8.5.7.5.1. Key Country Dynamics
      • 8.5.7.5.2. Competitive Scenario
      • 8.5.7.5.3. Regulatory Framework
      • 8.5.7.5.4. Reimbursement Scenario
      • 8.5.7.5.5. Kuwait Parenteral Nutrition Market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Key Company Market Position Analysis
  • 9.3. Key Company Market Share Analysis
  • 9.4. Recent Development and Impact Analysis, by key Market Participants
  • 9.5. Company Profiles
    • 9.5.1. Braun Melsungen AG
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Fresenius kabi AG
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Allergan
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Grifols S.A.
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Pfizer Inc.
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Otsuka Pharmaceutical Factory, Inc
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Baxter
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Aculife
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Sichuan Kelun Pharmaceutical Co., Ltd
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Vifor Pharma
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 4 North America Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 5 North America Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 6 North America Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 7 U.S. Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 8 U.S. Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 9 U.S. Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 10 U.S. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 11 Canada Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 12 Canada Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 13 Canada Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 14 Canada Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 15 Europe Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 16 Europe Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 17 Europe Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 18 Europe Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 19 UK Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 20 UK Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 21 UK Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 22 UK Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 24 Germany Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 25 Germany Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 26 Germany Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 27 France Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 28 France Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 29 France Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 30 France Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 31 Italy Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 32 Italy Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 33 Italy Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 34 Italy Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 35 Spain Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 36 Spain Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 37 Spain Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 38 Spain Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 39 Sweden Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 40 Sweden Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 41 Sweden Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 42 Sweden Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 43 Denmark Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 44 Denmark Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 45 Denmark Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 46 Denmark Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 47 Norway Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 48 Norway Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 49 Norway Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 50 Norway Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 55 Japan Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 56 Japan Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 57 Japan Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 58 Japan Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 59 China Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 60 China Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 61 China Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 62 China Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 63 India Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 64 India Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 65 India Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 66 India Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 67 Australia Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 68 Australia Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 69 Australia Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 70 Australia Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 71 South Korea Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 72 South Korea Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 73 South Korea Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 74 South Korea Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 75 Thailand Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 76 Thailand Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 77 Thailand Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 78 Thailand Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 79 Latin America Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 80 Latin America Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 81 Latin America Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 82 Latin America. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 83 Brazil Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 84 Brazil Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 85 Brazil Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 86 Brazil Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 87 Mexico Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 88 Mexico Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 89 Mexico Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 90 Mexico. Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 91 Argentina Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 92 Argentina Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 93 Argentina Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 94 Argentina Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 95 MEA Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 96 MEA Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 97 MEA Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 98 MEA Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 99 South Africa Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 100 South Africa Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 101 South Africa Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 102 South Africa Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 103 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 104 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 105 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 107 UAE Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 108 UAE Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 109 UAE Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 110 UAE Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)
  • Table 111 Kuwait Parenteral Nutrition market estimates and forecasts, by nutrient type, 2018 - 2030 (USD Million)
  • Table 112 Kuwait Parenteral Nutrition market estimates and forecasts, by stage, 2018 - 2030 (USD Million)
  • Table 113 Kuwait Parenteral Nutrition market estimates and forecasts, by indication, 2018 - 2030 (USD Million)
  • Table 114 Kuwait Parenteral Nutrition market estimates and forecasts, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity Flow Analysis
  • Fig. 9 Volume Price Analysis
  • Fig. 10 Parenteral nutrition market snapshot (2022)
  • Fig. 11 Parenteral nutrition market segmentation
  • Fig. 12 Parenteral nutrition market: Strategy framework
  • Fig. 13 Market trends and outlook
  • Fig. 14 Parent market outlook
  • Fig. 15 Related/ancillary market outlook
  • Fig. 16 Penetration & growth prospect mapping
  • Fig. 17 Market driver relevance analysis (Current & future impact)
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Parenteral nutrition market, nutrient type outlook: key takeaways (USD Million)
  • Fig. 20 Parenteral nutrition market: nutrient type movement analysis, 2022 & 2030 (USD Million)
  • Fig. 21 Carbohydrates market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Parenteral lipid emulsion market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Single dose amino acid solution market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Trace elements market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Vitamins & Minerals market estimates and forecasts, 2018 - 2030 (USD Million
  • Fig. 26 Parenteral nutrition market, stage type outlook: key takeaways (USD Million)
  • Fig. 27 Parenteral nutrition market: stage type movement analysis, 2022 & 2030 (USD Million)
  • Fig. 28 Adult market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Pediatrics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Parenteral nutrition market, Indication outlook: key takeaways (USD Million)
  • Fig. 31 Parenteral nutrition market: Indication movement analysis, 2022 & 2030 (USD Million)
  • Fig. 32 Alzheimer's market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Nutrition Deficiency market estimates and forecasts, 2018 - 2030 (USD Million
  • Fig. 34 Cancer Care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Diabetes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Chronic kidney disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Orphan disease market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Dysphagia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Pain management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Malabsorption/GI Disorder/Diarrhea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Parenteral nutrition market, regional marketplace: Key takeaways (USD Million)
  • Fig. 43 Parenteral nutrition market: regional movement analysis, 2022 & 2030 (USD Million)
  • Fig. 44 North America Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 U.S. Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Canada Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UK Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Italy Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Denmark Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Norway Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Thailand Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Mexico Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Argentina Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 MEA Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 UAE Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait Parenteral nutrition market estimates and forecasts, 2018 - 2030 (USD Million)